How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Recent insider activity for Recursion Pharmaceuticals Inc consisted of 1 transaction totaling $18,400.36. The transaction was a Tax Payment by Ben R Taylor, the company’s Chief Financial Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results